elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q24680238-55572062-3FBC-482B-ABDF-7C61AEB87A2F
Q24680238-55572062-3FBC-482B-ABDF-7C61AEB87A2F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24680238-55572062-3FBC-482B-ABDF-7C61AEB87A2F
Ibandronate: the first once-monthly oral bisphosphonate for treatment of postmenopausal osteoporosis
P2860
Q24680238-55572062-3FBC-482B-ABDF-7C61AEB87A2F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24680238-55572062-3FBC-482B-ABDF-7C61AEB87A2F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
87a09752a88c548b467ef96823c76ce8b8a3241c
P2860
A semimechanistic and mechanistic population PK-PD model for biomarker response to ibandronate, a new bisphosphonate for the treatment of osteoporosis.